Anti-C5aR antibody shows promise as immuno-oncology treatment
Pre-clinical studies have shown that the TJ210/MOR210 monoclonal antibody is…
Pre-clinical studies have shown that the TJ210/MOR210 monoclonal antibody is successful at targeting tumours.